MarketCap
Facebook
X
TelegramAnnual report 2026
added 03-17-2026
HealthEquity Income Statement 2011-2026 | HQY
Annual Income Statement HealthEquity
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
6.84 B | 6.9 B | 6.81 B | 4.85 B | 4.77 B | 3.28 B | 4.76 B | 5.15 B | 3.34 B | 2.52 B | 1.21 B | 651 M | - | - | - | - |
Shares |
86.1 M | 86.9 M | 85.6 M | 84.4 M | 83.1 M | 74.2 M | 67 M | 61.8 M | 60.3 M | 58.6 M | 56.7 M | 31.2 M | - | - | - | - |
Historical Prices |
79.4 | 79.4 | 79.6 | 57.4 | 57.4 | 44.2 | 69.7 | 74.1 | 59.6 | 46.7 | 40.5 | 25.1 | 25.4 | - | - | - |
Net Income |
215 M | 96.7 M | 55.7 M | 14.7 M | -1.64 M | 8.83 M | 39.7 M | 73.9 M | 47.4 M | 26.4 M | 16.6 M | 10.2 M | 1.23 M | 11.2 M | - | - |
Revenue |
1.31 B | 1.2 B | 1 B | 249 M | 216 M | 734 M | 532 M | 287 M | 230 M | 178 M | 127 M | 87.9 M | 62 M | 46.1 M | - | - |
Cost of Revenue |
400 M | 423 M | 377 M | 90 M | 88.8 M | 318 M | 206 M | 106 M | 94.6 M | 72 M | - | - | - | - | - | - |
Gross Profit |
913 M | 777 M | 623 M | 159 M | 127 M | 415 M | 326 M | 181 M | 135 M | 106 M | 72.6 M | 48 M | 32.8 M | 24.1 M | - | - |
Operating Income |
322 M | 162 M | 118 M | 9.06 M | -24.2 M | 34 M | 77 M | 77.7 M | 54.4 M | 41.2 M | 26.1 M | 16.9 M | 11.5 M | 7.09 M | - | - |
Interest Expense |
12.1 M | 14.3 M | 12.8 M | 48.4 M | 36.6 M | 34.9 M | 24.8 M | 270 K | 274 K | -1.09 M | -589 K | - | 44 K | 326 K | - | - |
EBITDA |
477 M | 325 M | 271 M | 170 M | 113 M | 150 M | 144 M | 83.6 M | 59.3 M | 45.5 M | 28.4 M | 18.5 M | 13.2 M | 8.73 M | - | - |
Operating Expenses |
591 M | 615 M | 505 M | 128 M | 122 M | 381 M | 217 M | 104 M | 80.5 M | 65.1 M | 46.5 M | 31.1 M | 21.3 M | 17 M | - | - |
General and Administrative Expenses |
120 M | 132 M | 104 M | 97.5 M | 85.4 M | 84.5 M | 60.6 M | 33 M | 25.1 M | 20.2 M | 14.1 M | 8.34 M | 3.9 M | 3.37 M | - | - |
All numbers in USD currency
Quarterly Income Statement HealthEquity
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
86 M | 86.6 M | 86.7 M | 86.5 M | 87.2 M | 87.1 M | 86.5 M | 86.1 M | 85.7 M | 85.5 M | 85 M | 84.8 M | 84.6 M | 84.4 M | 84 M | 77.2 M | 83.6 M | 83.5 M | 81.7 M | 71.1 M | 76.7 M | 72.3 M | 71 M | 62.4 M | 70.5 M | 64.2 M | 62.3 M | 60.8 M | 62.1 M | 61.9 M | 61.2 M | 59.5 M | 60.6 M | 60.2 M | 59.7 M | 57.7 M | 58.9 M | 58.2 M | 57.8 M | 54.8 M | 57.4 M | 56.7 M | 55.1 M | 7.04 M | 53.7 M | 8.14 M | 7.37 M | - | 5.58 M | 5.57 M | - | - | - | - | - | - | - | - | - |
Net Income |
51.7 M | 59.9 M | 53.9 M | - | 5.7 M | 35.8 M | 28.8 M | - | 14.7 M | 10.6 M | 4.09 M | - | -1.64 M | -10.7 M | -13.6 M | - | -5.04 M | -3.82 M | -2.62 M | -190 K | 1.79 M | -148 K | 1.83 M | 13.1 M | -21.3 M | 19.4 M | 41.8 M | 5.9 M | 15.7 M | 22.5 M | 22.6 M | 4.06 M | 10.5 M | 16.9 M | 14 M | 3.13 M | 6.01 M | 8.23 M | 8.07 M | 1.37 M | 4.09 M | 4.42 M | 4.98 M | -4.72 M | 3.05 M | 3.03 M | 2.72 M | - | 1.98 M | 2.22 M | 1.75 M | - | - | - | - | - | - | - | - |
Revenue |
322 M | 326 M | 331 M | - | 300 M | 300 M | 288 M | - | 249 M | 244 M | 244 M | - | 216 M | 206 M | 206 M | - | 180 M | 189 M | 184 M | 201 M | 179 M | 176 M | 190 M | 75.8 M | 157 M | 86.6 M | 87.1 M | 60.4 M | 70.5 M | 71.1 M | 69.9 M | 46.8 M | 56.8 M | 56.9 M | 55.4 M | 35.9 M | 43.4 M | 44.2 M | 44 M | 24.9 M | 30.6 M | 30.5 M | 29.8 M | 17.2 M | 21.9 M | 20.9 M | 20.2 M | - | 15.2 M | 15 M | 14.6 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
94.1 M | 93.2 M | 107 M | - | 103 M | 95.9 M | 100 M | - | 90 M | 91.9 M | 96 M | - | 89.2 M | 88.3 M | 94.5 M | - | 76.6 M | 77.1 M | 81.1 M | 87.5 M | 74.8 M | 74.3 M | 81.9 M | 31.3 M | 61.1 M | 28.2 M | 29.3 M | 28.8 M | 24.7 M | 24.5 M | 25.5 M | - | 23.1 M | 21.1 M | 21.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
228 M | 233 M | 224 M | - | 197 M | 204 M | 187 M | - | 159 M | 152 M | 148 M | - | 127 M | 118 M | 111 M | - | 103 M | 112 M | 103 M | 114 M | 105 M | 102 M | 108 M | 44.4 M | 96 M | 58.4 M | 57.8 M | 31.6 M | 45.8 M | 46.6 M | 44.4 M | 24.2 M | 33.7 M | 35.8 M | 33.7 M | 18.4 M | 25.9 M | 28.6 M | 27.7 M | 12.5 M | 17.7 M | 18.6 M | 17.9 M | 8.42 M | 12.2 M | 11.8 M | 11.5 M | - | 8.38 M | 8.34 M | 7.66 M | - | - | - | - | - | - | - | - |
Operating Income |
78.7 M | 89.6 M | 83.1 M | - | 19.6 M | 58.9 M | 41.6 M | - | 30.9 M | 24.7 M | 23.2 M | - | 5.54 M | -2.41 M | -7.29 M | - | -366 K | -875 K | 4.25 M | - | 11.5 M | 9.03 M | 15.1 M | - | 9.92 M | 24.9 M | 27.7 M | - | 19 M | 21.6 M | 20.5 M | - | 13.6 M | 16.5 M | 15.9 M | - | 9.04 M | 12.7 M | 13.2 M | - | 6.3 M | 7.5 M | 7.98 M | - | 4.29 M | 5.07 M | 5.49 M | - | 3.4 M | 3.61 M | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.89 M | 3.39 M | 2.73 M | - | 4.75 M | 3.11 M | 3.4 M | - | 3.74 M | 2.76 M | 15 M | - | 12.2 M | 11.5 M | 10.5 M | - | 11.9 M | 7.25 M | 6.69 M | - | 6.95 M | 8.9 M | 12.3 M | -221 K | 10.2 M | 67 K | 63 K | -1.71 M | 68 K | -75 K | -1 K | -158 K | -395 K | -38 K | -90 K | -63 K | -256 K | -37 K | -641 K | -98 K | 121 K | -542 K | -105 K | - | -145 K | - | -827 K | - | -138 K | 10 K | - | - | - | - | - | - | - | - | - |
EBITDA |
79.1 M | 90.1 M | 122 M | - | 20.6 M | 60.2 M | 80.6 M | - | 32.7 M | 26.7 M | 62.2 M | - | 8.44 M | 788 K | 32.2 M | - | 98 M | 63.9 M | 36 M | - | 97 M | 65.1 M | 42.6 M | - | 38.7 M | 34.6 M | 32.5 M | - | 32.5 M | 22.4 M | 25.1 M | - | 14.3 M | 23.6 M | 19.4 M | - | 18.6 M | 18.9 M | 16.2 M | 1.1 M | 12 M | 11.2 M | 9.73 M | 728 K | 8.48 M | 7.71 M | 6.74 M | - | 6.54 M | 5.6 M | - | - | - | - | - | - | - | - | - |
Operating Expenses |
149 M | 143 M | 141 M | - | 177 M | 145 M | 146 M | - | 128 M | 127 M | 125 M | - | 121 M | 120 M | 118 M | - | 104 M | 113 M | 98.9 M | 99.1 M | 93.1 M | 92.8 M | 93 M | 27.9 M | 86.1 M | 33.6 M | 30.1 M | 23.2 M | 26.8 M | 25 M | 23.8 M | 18 M | 20.2 M | 19.3 M | 17.8 M | 14.1 M | 16.8 M | 15.8 M | 14.4 M | 10.5 M | 11.4 M | 11.1 M | 9.92 M | 6.83 M | 7.94 M | 6.7 M | 5.97 M | - | 4.98 M | 4.73 M | 4.73 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
30.9 M | 30 M | 25.5 M | - | 31.8 M | 32.3 M | 38.2 M | - | 27.2 M | 27.8 M | 25.5 M | - | 25.1 M | 25.9 M | 23.7 M | - | 20 M | 22.8 M | 20.7 M | - | 22.1 M | 20.5 M | 19 M | - | 19.2 M | 9.26 M | 8.71 M | - | 9.16 M | 7.89 M | 7.51 M | - | 6.25 M | 6.23 M | 5.87 M | - | 5.17 M | 5.55 M | 4.57 M | - | 3.48 M | 3.94 M | 3.16 M | - | 2.44 M | 1.67 M | 1.14 M | - | 894 K | 825 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
The income statement is one of the three key financial reports of a company HealthEquity (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Health information services industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Accolade
ACCD
|
- | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
- | - | $ 9.03 B | USA |
 |
Phreesia
PHR
|
$ 11.27 | -0.13 % | $ 615 M | USA |
 |
Cerner Corporation
CERN
|
- | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
$ 5.77 | 0.17 % | $ 92.6 M | USA |
 |
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
- | - | $ 2.94 B | USA |
 |
Schrödinger
SDGR
|
$ 11.51 | -0.52 % | $ 845 M | USA |
 |
iCAD
ICAD
|
- | - | $ 102 M | USA |
 |
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | USA |
 |
Teladoc Health
TDOC
|
$ 5.57 | 2.87 % | $ 982 M | USA |
 |
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
- | - | $ 3.37 B | USA |
 |
Premier
PINC
|
- | - | $ 2.33 B | USA |
 |
Omnicell
OMCL
|
$ 34.87 | 1.19 % | $ 1.61 B | USA |
 |
OptimizeRx Corporation
OPRX
|
$ 7.15 | 5.38 % | $ 122 M | USA |
 |
Evolent Health
EVH
|
$ 2.28 | 1.11 % | $ 214 M | USA |
 |
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | USA |
 |
SCWorx Corp.
WORX
|
$ 0.13 | 3.86 % | $ 190 K | USA |
 |
GoodRx Holdings
GDRX
|
$ 2.07 | 1.23 % | $ 798 M | USA |
 |
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | USA |
 |
Zhongchao
ZCMD
|
$ 1.82 | 0.28 % | $ 9.47 M |  China |
 |
R1 RCM
RCM
|
- | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
- | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | USA |
 |
Health Catalyst
HCAT
|
$ 1.11 | 0.91 % | $ 77.6 M | USA |
 |
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | USA |
 |
HealthStream
HSTM
|
$ 21.18 | 1.0 % | $ 644 M | USA |
 |
10x Genomics
TXG
|
$ 20.98 | 5.91 % | $ 2.46 B | USA |
 |
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | USA |
 |
Progyny
PGNY
|
$ 17.65 | -2.22 % | $ 1.51 B | USA |
 |
So-Young International
SY
|
$ 3.11 | 6.87 % | $ 247 M | China |
 |
Veeva Systems
VEEV
|
$ 178.22 | -0.5 % | $ 29.2 B | USA |